Trial Profile
Advair Alvesco combination therapy:AVEC study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2019
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms AVEC
- 22 Aug 2018 Status changed from active, no longer recruiting to completed.
- 12 Nov 2013 New trial record